This complimentary, web-based program, supported by an independent medical education grant from Quest Diagnostics, provides clinicians with the opportunity to earn CME credit while learning how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in the diagnosis and management of breast cancer.
Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and clinicians need to make better health care decisions.
More than half a million patients every day—nearly 150 million patients every year—benefit from our solutions and commitment to creating a healthier world.
We are focused on providing access to testing with our extensive capabilities and services that make testing easier and more affordable.
BRCAvantage™ combines testing expertise with extensive support services to deliver results you can trust:
“BRCAvantage™ Testing and Services: An In-Depth Discussion” is presented by Frederic Waldman, M.D., Ph.D., Medical Director, Cancer Diagnostics, Quest Diagnostics Nichols Institute, and Wendy Conlon, MS, CGC, Quest Diagnostics Nichols Institute.
Topics covered include: